Takeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....

Gujarat health officials reported twenty-two deaths and thirty-five Chandipura virus cases. Seven patients remain in intensive care units r...

The Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...

India is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...

Travelers from India to the UAE must check airline and customs regulations before packing. Certain food items like copra and poppy seeds ar...

Demand for nutrition professionals is rapidly rising across India. Hospitals and digital health platforms are hiring more dietitians and ed...

Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...

Amid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....

PAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...

India plans major healthcare regulatory changes soon. These reforms aim to simplify licensing and reduce compliance burdens. The govt will ...

The FDA has approved Lipfendra, an oral PCSK9 inhibitor, for high cholesterol. This new once-daily pill offers an alternative to injectable...

The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...

US pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...

India's merchandise exports to its free trade agreement (FTA) partner countries rose 25% year-on-year to $43.14 billion in the April-June q...

Production Linked Incentive schemes, which aim to boost manufacturing and attract significant investments, have disbursed Rs 35,354 crore t...

Akums Drugs and Pharmaceuticals will acquire Oriflame India's manufacturing business. This significant deal is valued at fifty-six crore ru...

Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...